To include your compound in the COVID-19 Resource Center, submit it here.

ALS group launches trial of digital app to track progression

A new mobile app could help patients, physicians and drug developers track amyotrophic lateral sclerosis disease progression to better understand whether an investigational therapy is working and learn more about the natural history of the disease.

The ALS Never Surrender Foundation will

Read the full 410 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers